CEO
MDx CRO
Barcelona, Catalonia, Spain
Carlos has spent the past 18 years in the IVD sector, primarily at the renowned Notified Body, BSI. There, he not only built an extensive global network with leading EU Notified Bodies but also pioneered as the first in-house clinician for IVDs. Carlos spearheaded the BSI clinical oversight process, paving the way for hundreds of CE markings for IVDs. Prior to his regulatory roles, Carlos honed his expertise as a senior scientist in prestigious UK diagnostic institutions, working with various IVD technologies giving him a thorough understanding of the field’s unique demands. Beyond BSI, Carlos served as Vice President for Diagnostics at a large medtech consultancy and was also a medicines inspector with the MHRA. Currently, he is the founder and CEO at MDx CRO and leads several precision medicine programs with the world´s largest pharmaceutical and diagnostic companies. He also works as an external expert to the EU Commission, sharing his vast knowledge and experience with a variety of stakeholders.
Tuesday, May 5, 2026
08:30 - 16:00 WEST
Navigating Global CTR–IVDR Trials: Real-World Challenges and Practical Lessons
Wednesday, May 6, 2026
12:00 - 13:00 WEST
Friday, May 8, 2026
11:15 - 12:15 WEST